Masuda N, Tamura K, Yasojima H, Shimomura A, et al. Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer. BMC Cancer 2021;21:1269.
PMID: 34819039